Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer

This clinical trial tests the effect of focal radiation therapy, high dose rate-brachytherapy (HDR-BT), in treating patients with prostate cancer. Prostate cancer is the most diagnosed cancer in men and there are many treatments available, including surgery and radiation therapy. Although surgery and radiation therapy improve survival urinary and sexual function can be significantly affected and can be long lasting. HDR-BT, a type of focal radiation therapy also known as internal radiation therapy, uses radioactive material placed directly into or near a tumor to kill tumor cells. Giving HDR-B

Trial Details

NCT ID
NCT07468903
Phase
NA
Sponsor
Jonsson Comprehensive Cancer Center
Status
RECRUITING
Cancer Type
Prostate Cancer
Interventions
  • Biopsy Procedure
  • Biospecimen Collection
  • High-Dose Rate Brachytherapy
  • Multiparametric Magnetic Resonance Imaging
  • PSMA PET Scan
  • Questionnaire Administration
Locations (sample)
  • Los Angeles, California, United States|34.05223,-118.24368

Key Eligibility Criteria

  • Histologically confirmed diagnosis of prostate adenocarcinoma within 90 days prior to registration via systematic biopsy
  • Multiparametric MRI (mp-MRI) confirmed lesion(s)
  • No distant or locally advanced disease on standard staging exams as indicated
  • Bone scan and abdominopelvic computed tomography (CT)/MRI OR

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Prostate Cancer Trials on Trialify →